Cardlytics, Inc.
Cardlytics, Inc. is listed today as Cardlytics, Inc.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2017 | $12 M | No. 1 | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Cardlytics, Inc., its revenue in fiscal 2025 came from these product and service lines: Cost per Redemption $129.29 million (55%), Cost per Served Sales $79.06 million (34%), Bridg Total Revenue $20.94 million (9%), Bridg Subscription Revenue $20.94 million (9%), Cost Other $3.97 million (2%).
Annual report (SEC XBRL) · Dec 2025
Cardlytics, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2017).
SEC Form D · Jun 2017
The industry group it chose in its notices: Other Technology.
SEC Form D · Jun 2017
Products and services#
No products or services of Cardlytics, Inc. are on record.
Investors#
15 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Aeroplan Holdings Europe Sarl | Other | not stated | not stated | Held Series C-R, D-R, E-R and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Aimia Holdings UK Ltd | Company | not stated | not stated | Held Series C-R, D-R, E-R and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Aimia Inc. | Company | not stated | not stated | Held Series C-R, D-R, E-R and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Canaan Partners VIII LLC | Fund or asset manager | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| Canaan VIII LP | Fund or asset manager | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| David Leslie Adams | Person | not stated | not stated | Held Series G preferred stock, director (Form 3, 2018) | SEC Form 3 |
| John L. Klinck Jr. | Person | not stated | not stated | Held Series G preferred stock, director (Form 3, 2018) | SEC Form 3 |
| Lynne Marie Laube | Person | not stated | not stated | Held Series G preferred stock, director (Form 3, 2018) | SEC Form 3 |
| Mark A. Johnson | Person | not stated | not stated | Held Series G preferred stock, director (Form 3, 2018) | SEC Form 3 |
| Polaris Venture Management Co. V, L.L.C. | Venture capital | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| Polaris Venture Partners Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| Polaris Venture Partners V, L.P. | Venture capital | not stated | not stated | Held Series A-R, B-R, C-R, D-R, E-R and G preferred (Form 3, 2018) | SEC Form 3 |
| Scott D. Grimes | Person | not stated | not stated | Held Series G preferred stock, director (Form 3, 2018) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 14 investors.
Largest shareholders today
Institutions holding Cardlytics, Inc. shares, as of Sep 30, 2026.
- Vanguard Capital Management LLC$1 M3.58%
- 683 Capital Management, LLC$1 M3.28%
- KPS Global Asset Management UK Ltd$0 M2.00%
- Worldly Partners Management, LLC$0 M1.90%
- BlackRock, Inc.$0 M1.35%
- RBF Capital, LLC$0 M1.31%
- Geode Capital Management, LLC$0 M1.05%
- Quinn Opportunity Partners LLC$0 M0.76%
- Vanguard Fiduciary Trust Co$0 M0.54%
- UBS Group AG$0 M0.45%
- LPL Financial LLC$0 M0.41%
- State Street Corp$0 M0.37%
- Kingsbury Capital Investment Advisors LLC$0 M0.34%
- Gsa Capital Partners LLP$0 M0.33%
- Citadel Advisors LLC$0 M0.32%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Evans | Executive officer | Jun 2017 |
| Kirk Somers | Executive officer | Jun 2017 |
| Lynne Laube | Executive officer | Jun 2017 |
| Scott Grimes | Executive officer | Jun 2017 |
| Bryce Youngren | Director | Jun 2017 |
| David Adams | Director | Jun 2017 |
| John Balen | Director | Jun 2017 |
| John Klinck | Director | Jun 2017 |
| Lynne Laube | Director | Jun 2017 |
| Mark Johnson | Director | Jun 2017 |
| Robert Legters | Director | Jun 2017 |
| Scott Grimes | Director | Jun 2017 |
| Tony Weisman | Director | Jun 2017 |
About
American company.
Went public since 2018. Its SEC number is that of a company listed on a stock exchange.